Narayana Hrudayalaya Reports Robust Q2 FY26 Performance: 20% EBITDA Growth and Strong Cayman Operations

2 min read     Updated on 24 Nov 2025, 05:06 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Narayana Hrudayalaya (NH) delivered impressive Q2 FY26 results, with revenue up 19.98% to ₹1,668.00 crore and EBITDA growing 28.21% to ₹425.40 crore. Net profit increased 30.03% to ₹258.50 crore. India operations saw 20% EBITDA growth despite reduced bed capacity. Cayman Islands operations showed 70% growth in insurance business revenue. NH performed 97 robotic cardiac surgeries in September, highlighting its focus on advanced procedures. The company completed the acquisition of Practice Plus in the UK, expanding its global presence.

25529817

*this image is generated using AI for illustrative purposes only.

Narayana Hrudayalaya (NH) has delivered an impressive performance in Q2 FY26, showcasing strong growth across its operations in India and the Cayman Islands. The company's strategic focus on payor-mix optimization and high-end procedures has yielded significant results, particularly in its EBITDA growth and international expansion.

Key Highlights

  • EBITDA Growth: NH reported a remarkable 20% year-on-year EBITDA growth in its India operations, despite a reduction in bed capacity.
  • Cayman Islands Performance: The company's Cayman Islands operations showed exceptional growth, with a 70% increase in insurance business revenue.
  • Advanced Procedures: NH performed 97 robotic cardiac surgeries in September alone, highlighting its commitment to cutting-edge medical technologies.
  • International Expansion: The company completed the acquisition of Practice Plus in the UK, further strengthening its global presence.

Financial Performance

Metric Q2 FY26 Q2 FY25 YoY Change
Revenue ₹1,668.00 crore ₹1,390.20 crore 19.98%
EBITDA ₹425.40 crore ₹331.80 crore 28.21%
Net Profit ₹258.50 crore ₹198.80 crore 30.03%
EPS ₹12.72 ₹9.76 30.33%

NH's financial performance in Q2 FY26 demonstrates robust growth across key metrics. The company's revenue increased by 19.98% year-on-year, while EBITDA saw a significant jump of 28.21%. Net profit and EPS also showed strong growth, increasing by 30.03% and 30.33% respectively.

Operational Highlights

India Operations

The 20% EBITDA growth in India operations is particularly noteworthy, given that it was achieved with reduced bed capacity. This growth can be attributed to:

  1. Payor-Mix Optimization: NH has successfully improved its payor mix, focusing on higher-paying patients and more lucrative insurance contracts.
  2. High-End Procedures: The company has increased its focus on complex, high-value medical procedures, including robotic surgeries.
  3. Operational Efficiency: Despite reduced capacity, NH has managed to improve its operational metrics, indicating better resource utilization.

Cayman Islands Operations

The Cayman Islands business continues to be a strong growth driver for NH:

  • Insurance Business: 70% year-on-year revenue growth in the insurance segment.
  • Hospital Performance: The Cayman hospital maintained impressive margins of 43-44%.

Technological Advancements

NH's commitment to advanced medical technologies is evident from the 97 robotic cardiac surgeries performed in September. This focus on cutting-edge procedures not only improves patient outcomes but also contributes to higher revenue per patient.

International Expansion

The completion of the Practice Plus acquisition in the UK marks a significant milestone in NH's international growth strategy. This move is expected to:

  1. Diversify NH's geographical presence
  2. Provide access to new markets and technologies
  3. Potentially lead to knowledge transfer and operational synergies

Conclusion

Narayana Hrudayalaya's Q2 FY26 results demonstrate the company's ability to drive growth through strategic initiatives and operational excellence. The strong performance in both domestic and international markets positions NH well in the healthcare sector. However, investors should note that the healthcare sector can be subject to regulatory changes and economic fluctuations, which may impact future performance.

Historical Stock Returns for Narayana Hrudayalaya

1 Day5 Days1 Month6 Months1 Year5 Years
-3.30%-1.61%+13.89%+11.19%+57.35%+415.94%
Narayana Hrudayalaya
View in Depthredirect
like20
dislike

Narayana Hrudayalaya Shares Surge 10% on Strong Q2 Results and Expansion Plans

1 min read     Updated on 17 Nov 2025, 10:39 AM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Narayana Hrudayalaya's shares rose 10% following the announcement of robust Q2 FY24 results and ambitious expansion plans. The company reported a 20.30% YoY increase in revenue to 1,643.79 crore and a 29.90% YoY growth in net profit to 258.83 crore. Narayana Hrudayalaya plans to expand its bed capacity from the current 5,750 to over 7,650 beds by FY30, signaling confidence in growing healthcare demand in India.

24901804

*this image is generated using AI for illustrative purposes only.

Shares of Narayana Hrudayalaya , a prominent healthcare operator in India, witnessed a significant uptick of 10% following the announcement of its robust quarterly results and ambitious expansion plans.

Strong Q2 Performance

The company reported impressive financial results for the second quarter:

Metric Q2 FY24 YoY Growth
Revenue 1,643.79 20.30
Net Profit 258.83 29.90

The substantial growth in both revenue and net profit underscores Narayana Hrudayalaya's strong operational performance and increasing market demand for its healthcare services.

Expansion Strategy

Narayana Hrudayalaya has unveiled plans for significant expansion, aiming to increase its bed capacity:

Timeline Current Capacity Targeted Capacity
Current 5,750 beds -
By FY30 - Over 7,650 beds

This expansion strategy signals the company's commitment to aggressive growth and its confidence in the increasing demand for quality healthcare services in India.

Market Response

The market responded positively to Narayana Hrudayalaya's performance and future outlook:

  • Share price surged by 10%
  • Investors showed enthusiasm for the company's growth trajectory
  • The expansion plans were well-received, indicating market confidence in the company's long-term strategy

Narayana Hrudayalaya's strong quarterly performance, coupled with its ambitious expansion plans, has positioned the company favorably in the competitive healthcare sector. The significant increase in share price reflects investor optimism about the company's future prospects and its ability to capitalize on the growing healthcare market in India.

Historical Stock Returns for Narayana Hrudayalaya

1 Day5 Days1 Month6 Months1 Year5 Years
-3.30%-1.61%+13.89%+11.19%+57.35%+415.94%
Narayana Hrudayalaya
View in Depthredirect
like15
dislike
More News on Narayana Hrudayalaya
Explore Other Articles
1,975.80
-67.40
(-3.30%)